Source:http://linkedlifedata.com/resource/umls/id/C1522188
HL7V3.0: <p>Buccal mucosa</p>,NCI: Administration directed toward the cheek, generally from within the mouth. (FDA),NCI: Administration of a substance through the mucosal membrane on the inside of the cheek or the back of the mouth. Buccal route bypasses first pass metabolism and avoids pre-systemic elimination in the gastrointestinal tract. The buccal environment is well supplied with both vascular and lymphatic drainage and is well suited for a retentive device. This is a feasible alternative for systemic delivery of orally inefficient drugs, such as peptide and protein drug molecules.,HL7V3.0: <p>Buccal mucosa</p>